Tenax Therapeutics (TENX) Share-based Compensation (2016 - 2017)
Historic Share-based Compensation for Tenax Therapeutics (TENX) over the last 8 years, with Q4 2017 value amounting to $64.0.
- Tenax Therapeutics' Share-based Compensation fell 6862.75% to $64.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $79589.0, marking a year-over-year increase of 739425.61%. This contributed to the annual value of $1.1 million for FY2024, which is 48900.52% up from last year.
- According to the latest figures from Q4 2017, Tenax Therapeutics' Share-based Compensation is $64.0, which was down 6862.75% from $67.0 recorded in Q2 2017.
- Tenax Therapeutics' 5-year Share-based Compensation high stood at $1.4 million for Q1 2014, and its period low was $64.0 during Q4 2017.
- Moreover, its 5-year median value for Share-based Compensation was $14840.0 (2014), whereas its average is $320446.5.
- Per our database at Business Quant, Tenax Therapeutics' Share-based Compensation crashed by 9823.27% in 2015 and then soared by 2528594.25% in 2017.
- Quarter analysis of 5 years shows Tenax Therapeutics' Share-based Compensation stood at $1.3 million in 2013, then plummeted by 97.24% to $34868.0 in 2014, then crashed by 99.23% to $268.0 in 2015, then decreased by 23.88% to $204.0 in 2016, then plummeted by 68.63% to $64.0 in 2017.
- Its Share-based Compensation was $64.0 in Q4 2017, compared to $67.0 in Q2 2017 and $79458.0 in Q1 2017.